Health Care Industry Market Research

Competitive Intelligence, Business Analysis, Forecasts, Market Size, Trends, Companies, Statistics

Available Data Services: Custom Research Projects, Database Subsription or PDF eBooks

Health Care OVERVIEW

Health Expenditures and Services in the U.S.:
The health care market in the U.S. during 2023 was projected to include massive spending in the major categories of hospital care ($1,459 billion); dental, physician and clinical services ($930 billion); and prescription drugs ($411 billion), along with nursing home and home health care ($342 billion).  Registered U.S. hospitals totaled 6,129 properties in 2023, according to an American Hospital Association survey, containing 919,649 beds. 
Medicare, the U.S. federal government’s health care program for Americans 65 years or older, provided coverage to an estimated 66.6 million seniors during 2023.  National expenditures on Medicare for fiscal 2023 were projected to be $1,019 billion, including premiums paid by beneficiaries and health care costs covered by Medicare.  By 2030, the number of people covered by Medicare will balloon to about 76.8 million due to the massive number of Americans who will become of eligible age.
Medicaid is the federal government’s health care program for low-income and disabled persons (including qualified children), as well as certain groups of seniors in nursing homes.  Enrollment in Medicaid and CHIP (Children’s Health Insurance Program) combined was estimated at 83.3 by Plunkett Research million for 2023.  The majority of Medicaid/CHIP expenses were paid for by the federal government.  However, the states pick up a significant share of the cost, which is a massive burden on state budgets.
Health spending in the U.S., at about 18% of Gross Domestic Product (GDP) in 2022, is projected to grow steadily.  Health care spending in America accounts for a larger share of GDP than in any other country, by a wide margin.  Despite the incredible investment America continues to make in health care, 7.9% of people in the U.S. (25.9 million) lacked health care coverage for at some point in 2022.  For some, insurance was unavailable or unaffordable.  In other cases, the lack of insurance was due to a personal decision not to pay for it.  According to the Kaiser Family Foundation, most uninsured people are in low-income working families, but a large segment of those counted among America’s uninsured are non-U.S. citizens, both lawful and illegal residents.
In March 2010, President Obama signed the Patient Protection and Affordable Care Act (ACA), designed to strengthen insurance company regulation and provide medical coverage to millions of uninsured Americans.  The act called for sweeping changes.  Provisions taking effect within the first six months of signing included coverage for adult children up to age 26 on their parents’ policies; making it unlawful for insurers to place lifetime caps on payouts or deny coverage should a policy holder become ill; and new policies are required to pay the full cost of selected preventive care and exempt such care from deductibles.  Small businesses with fewer than 25 employees and average annual wages of less than $50,000 became eligible for tax credits to cover up to 35% of staff insurance premiums.
Online health care insurance “exchanges” began enabling consumers to shop for health coverage.  A 3.8% unearned income tax is levied on individuals earning more than $200,000 per year and families earning more than $250,000 per year, to fund the programs in the act.  As of 2016, employers, with the equivalent of 50 full-time employees, which do not offer health benefits pay a fine per full time staff member if any of the workers receives a tax credit to buy coverage.  A similar fine took effect in 2015 for employers with the equivalent of 100 full-time employees.  Most businesses with more than 200 employees are required to enroll all staff automatically in health insurance plans.  Consumers whose annual incomes do not exceed set amounts may receive federal financial assistance if they purchase their own health insurance.
 
Health Expenditures Globally and in OECD Developed Nations:
A comprehensive study published by the Organization for Economic Cooperation & Development (OECD) covering more than 30 nations, including the majority of the world’s most developed economies (but excluding Brazil, Russia, India or China), found stark contrasts between health costs in the United States and those of other nations.  In 2021 (the latest complete data available), the average of a list that includes, for example, the UK, France, Germany, Mexico, Canada, South Korea, Japan, Australia and the U.S., spent 9.7% of GDP (gross domestic product—a measure of a nation’s economy) on health care.  The highest figures in this study were in America at 17.4% of GDP (which is actually a little low compared to U.S. government estimates), Germany at 12.9%, the UK at 12.4%, France at 12.3%, Canada at 12.3%, Austria at 12.1%, Switzerland at 11.8%, The Netherlands at 11.4%, Japan at 11.3%, Sweden at 11.2% and Portugal at 11.1%.
Total health care expenditures around the world are difficult to determine.  However, $11.2 trillion would be a reasonable estimate for the formal, global health care market for 2022.  That would place health care at roughly 11.2% of global GDP and about $1,485 in health spending per person on average.  In the U.S. and other developed nations, the per capita number is much higher.  The federal government forecast 2022 spending at $12,407 per capita for 2022.  The trend over the near future is for the modest amount now spent on health care in emerging nations to rise dramatically, while OECD nations like America struggle to contain their own mountainous costs.  Globally, the total prescription drug market was $1.4 trillion in 2022.
Health Care Costs in the U.S.
Particularly in the U.S., continuous increases in the cost of health care, growing at rates far exceeding the rate of inflation in general, have been inflicting financial pain on health consumers and payers of all types.  Government agencies are strained by the ever-growing cost of public health care programs such as Medicare, while employers are hit hard by vast increases in the cost of providing coverage to employees and retirees.
Many major employers are utilizing unique new programs in efforts to reduce employee illness, and thereby cut costs.  For example, the use of preventive care programs is growing, as is the use of employee education aimed at better managing the effects of diseases such as diabetes.  Some very large employers are even hiring in-house physicians and nurses, or contracting with outside providers for on-premises care facilities, to offer primary and preventive care in the workplace.
Patients and insurance companies are also dealing with sticker shock over the nation’s prescription drug costs.  Other factors edging costs upward include expensive new medical technologies and patients’ demands for greater flexibility in choosing doctors and specialists at their own discretion.  At the same time, hospitals and health systems write off massive amounts of potential revenues to bad debt, which increases costs for bill-paying patients.
In the wake of the tremendous growth of all aspects of the health care industry from the end of World War II onward, efficiency, competition, price transparency and productivity were, regretfully, largely overlooked.  Much of this occurred because employers, plus federal and state governments, pay such a large portion of the health care bill, to the extent that patients were generally not sensitive to health care costs.
The Centers for Disease Control and Prevention (CDC) reported recently that six in ten Americans suffer with at least one chronic disease such as cancer, diabetes, heart disease, pulmonary conditions, stroke or hypertension.  In addition to the massive cost of health care for these patients, the lost time at work and lost economic output due to these illnesses substantially reduced the nation’s GDP.  These burdens could be vastly reduced through better consumer health practices and better preventive medicine.  For example, obesity, lack of exercise and cigarette smoking are immense contributors to these diseases.  The CDC reported that medical costs for obesity-related diseases (which affect 20% of children and 42% of adults) rose as high as $173 billion in 2021, compared to $74 billion in 1998.  

The American health care industry faces more challenges than ever, due to many significant factors:
=         One of the most dramatic results of the Affordable Care act of 2010 has been consolidation within the hospital industry, with mergers creating massive organizations that in many cases have a dominant, regional or city-wide market share.  A similar effect has been a migration of physicians leaving private practice or small clinics in order to join giant physician practice groups or the staffs of hospitals.  Independent physicians are concerned about their ability to meet increased regulatory scrutiny, successfully deploy electronic health records and earn the incomes that they desire.  Many older physicians state that they will simply retire earlier than they had planned.
=         The U.S. population is aging rapidly.  At the same time, the life expectancy of seniors is extending.  Senior citizens will place a significant strain on the health care system in coming years.  America’s millions of surviving Baby Boomers began turning 65 in 2011.
=         The future obligations of Medicare and Medicaid are enough to cause vast problems for federal and state budgets for decades to come.  The number of seniors covered by Medicare will continue to grow at an exceedingly high rate, from 47.4 million people in 2010 to 77  million in 2030.
=         Likewise, costs for Medicaid, which is administered at the state level, have grown so rapidly that they are competing fiercely for budget dollars that might otherwise go to education and other vital state-provided services.
=         High, and growing, pharmaceutical costs have created a large backlash among health consumers and payers.  Some of the newest cancer drugs cost more than $500,000 to cover one treatment period.
=         We are now in what will long be remembered as the beginning of the Biotech Era.  Breakthroughs in research for targeted drug therapies, immunotherapies, genetic testing and synthetic biology are occurring at a rapid pace, and highly advanced, genetically engineered drugs are available for many diseases.
=         Due to rising costs, employers large and small are straining under the financial burden of health care coverage expenses for current employees and retirees.
=         Physicians, hospitals, medical device makers and pharmaceutical manufacturers face daunting pressure from litigation and claims regarding malpractice.  Lawsuit reform legislation has recently been enacted in many states with very promising results.
=         Vast numbers of Americans fail to lead healthy lifestyles that would prevent disease and cut both the amount and the cost of medical care.  Obesity-related illnesses are adding an immense amount to the nation’s health care costs.  (The recently launched obesity drugs, such as Ozempic and Mounjaro, while relatively expensive themselves (about $1,000 monthly) could eventually lead to a dramatic reduction in obesity-related chronic diseases, and thus an overall reduction in the costs of treatment and care.)
=         The three biggest causes of death in the U.S. are heart disease, cancer and stroke.  Nearly one-fourth of America’s annual health expenditures go for treatment of these three killers.
=         Only a relatively modest amount of money is spent on preventive medicine and health education.  The vast majority of health care funds are spent on the treatment of chronic diseases as well as end-of-life care for dying patients.
Source: Plunkett Research, Ltd.
 

WE PROFILE HUNDREDS OF TOP COMPANIES:

See All

PLUNKETT PROVIDES IN-DEPTH STATISTICS TABLES COVERING THE FOLLOWING INDUSTRY TOPICS:

Top Companies Profiled

The following is a partial listing for this industry. As a subscriber, you will have access to the leading companies and top growth companies. This includes publicly-held, private, subsidiary and joint venture companies, on a global basis as well as in the U.S.


Hundreds of Top Companies Profiled, Including:

PLUNKETT PROVIDES UNIQUE ANALYSIS OF THE FOLLOWING TRENDS THAT ARE DRIVING THIS INDUSTRY:

Key Findings:

A complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms within the Health Care Industry. Gain vital insights that can help shape strategy for business development, product development and investments.

Key Features:

  • Business trends analysis
  • In-depth industry overview
  • Technology trends analysis
  • Forecasts
  • Spending, investment, and consumption discussions
  • In-depth industry statistics and metrics
  • Industry employment numbers

Additional Key Features Include:

Industry Glossary

Industry Contacts list, including Professional Societies and Industry Associations

Profiles of industry-leading companies

  • U.S. and Global Firms
  • Publicly held, Private and Subsidiaries
  • Executive Contacts
  • Revenues
  • For Public Companies: Detailed Financial Summaries

Pages: 676

Statistical Tables Provided: 22

Companies Profiled: 500

Geographic Focus: Global

Price: $399.99

Key Questions Answered Include:

  • How is the industry evolving?
  • How is the industry being shaped by new technologies?
  • How is demand growing in emerging markets and mature economies?
  • What is the size of the market now and in the future?
  • What are the financial results of the leading companies?
  • What are the names and titles of top executives?
  • What are the top companies and what are their revenues?

This feature-rich report covers competitive intelligence, market research and business analysis—everything you need to know about the Health Care Industry.

Plunkett Research Provides Unique Analysis of the Following Major Trends and Technologies Affecting the Health Care Industry

  1. Introduction to the Health Care Industry
  2. The Coronavirus’ Effect on the Health Care Industry
  3. Continued Rise in Health Care Costs
  4. Employers Fight Rapidly Growing Health Care Premiums/Require Employees to Pay a Significant Share of Costs
  5. Medicare and Medicaid Spending Continue to Surge/More Baby Boomers Hit 65+ Years of Age
  6. U.S. Affordable Care Act (ACA) of 2010 Rewrote the Rules and Increased Coverage, But Costs Continue to Rise
  7. Accountable Care Organizations (ACOs) and Hospital Mergers Result from the Affordable Care Act/Many Hospital Chains Grow Dramatically in Market Share
  8. Concierge Care/Direct Primary Care Are on the Rise/New Twists on House Calls
  9. Insurance Companies Change Strategies Due to Affordable Care Act (ACA) and Rapidly Rising Costs of Care
  10. Number of Uninsured Americans Declines But Remains High
  11. Health Sharing Ministries Attract Millions of Members
  12. Massive R&D Investment Required for Development and Approval of New Blockbuster Drugs/Drug Prices Soar
  13. Fast Track Drugs Come to Market in the U.S. with FDA Cooperation
  14. Generic Drugs Have Biggest Market Share By Unit Volume, but not by Total Revenues
  15. America Pays Higher Prices for Drugs Than Other Nations/U.S. Government Launches Drug Price Negotiation and Control Powers for Medicare
  16. Biotech and Orphan Drugs Create New Revenues for Drug Firms
  17. Revolutionary New Drugs (Ozempic, Wegovy) Treat Obesity, Diabetes and Addiction
  18. Quality of Care and Health Care Outcomes Data Are Available Online, Creating a New Level of Transparency
  19. Malpractice Suits Are Blamed for Rising Health Care Costs/Tort Reform Is Capping Awards for Damages
  20. Obesity Sparks Government, School and Corporate Initiatives/Snack Foods Get Healthier
  21. Health Care Goes Offshore, Medical Tourism and Clinical Trials Continue in China, India and Elsewhere
  22. Retail Clinics, Urgent Care Centers and Employer Sites Increase Health Care Options/Reduce Costs
  23. Health Care Industry Grows Rapidly in China, India and Mexico

The Outlook for Health Care Technology:

  1. Health Care Technology Introduction
  2. Electronic Health Records (EHR) Digitize Patient Records at an Accelerating Pace
  3. Telemedicine and Remote Patient Monitoring Rely on Wireless
  4. Stem Cells and 3D Printing—A New Era of Regenerative Medicine Takes Shape
  5. Health Care Robotics
  6. Patients’ Genetic Profiles Plummet in Price as DNA Sequencing Technologies Advance
  7. Advances for Cancer Patients in Chemotherapy and Radiation, Including Proton Beams and IMRT
  8. Better Imaging, including MRI, PET and 320-Slice CT, Creates Advances in Detection
  9. Artificial Intelligence (AI), Deep Learning and Machine Learning Advance into Commercial Applications, Including Health Care and Robotics

Plunkett Research Provides In-Depth Tables for the Following Health Care Industry Statistics

  1. U.S. Health Care Industry Overview
    1. U.S. Health Care Industry Statistics and Market Size Overview
    2. Global Health Statistics, 2017-2022
    3. Employment in the Health Care Industry, U.S.: 2018-June 2023
    4. U.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 2022
    5. The U.S. Drug Discovery & Approval Process
    6. Federal R&D & R&D Plant Funding for Health and Human Services, U.S.: Fiscal Years 2020-2022
  2. U.S. Health Care Expenditures & Costs
    1. The Nation's Health Dollar: 2023 Where It Came From (Projected)
    2. The Nation's Health Dollar: 2023 Where It Went (Estimated)
    3. National Health Expenditures & Annual Percent Change, U.S.: 2015-2031
    4. National Health Expenditures by Type of Expenditure with Affordable Care Act Impacts, U.S.: Selected Calendar Years, 2020-2031
    5. Hospital Care Expenditures & Annual Percent Change, U.S.: 2016-2031
    6. Nursing Home Care Expenditures & Annual Percent Change, U.S.: 2016-2031
    7. Home Health Care Expenditures & Annual Percent Change, U.S.: 2016-2031
    8. Prescription Drug Expenditures & Annual Percent Change, U.S.: 2016-2031
  3. Medicare & Medicaid
    1. Medicare Enrollment, 1975-2097
    2. Medicaid and CHIP Enrollment: Estimates, 2017-2023
  4. U.S. Health Insurance Coverage & The Uninsured
    1. Number & Percent of Persons of All Ages with and without Health Insurance Coverage, U.S.: 2007-2022
    2. Employers' Costs for Health Insurance, Amount & Percent of Total Compensation, U.S.: Selected Years, 2019-2023
  5. U.S. Vital Statistics & Population Indicators
    1. Prevalence of Obesity Among Adults, by Age, Sex and Race/Ethnicity: U.S., 2018

Organizations that have used our research and products

CUSTOM MARKET RESEARCH

We have deep experience in conducting market research projects and surveys (both B2B and B2C) for the world’s leading organizations. Competitive intel, market sizing, product opportunities validation, technologies analysis, economic and market forecasts. Both domestic and global markets—any industry, any geography.
More details

INDUSTRIES WE COVER

We cover all leading industry sectors, from retailing, healthcare and banking, to logistics, robotics/automation, digital technologies, wireless, travel and aerospace. Our proprietary data and reports keep you on the cutting edge of your industry of specific interest. Great for strategic, marketing, investment and consulting professionals.lib
More details

INDUSTRY ANALYTICS REPORTS

Industry-specific operating benchmarks, industry financial statement averages, revenue forecasts, market size, statistics, company ranks and comparisons. Choose from 550+ Industries. Updated regularly. Instant download. Our unique reports save you countless hours of research time and effort. Used by the world’s top consulting, strategy and investment pros.
More details

CORPORATE BENCHMARKS REPORTS

Company-specific operating benchmarks (current and historical), benchmarked against industry-peers’ averages. Revenue forecasts, market size, statistics, company ranks and comparisons. Choose from 4000+ companies. Updated regularly. Instant download. Our unique reports save you countless hours of research time and effort. Used by the world’s top consulting, strategy and investment pros.
More details

Related Products

Biotechnology, Pharmaceuticals & Genetics Industry Market Research

Biotechnology can be defined as the use of living organisms (such as bacteria), biological processes or biological systems to create a desired end-result or end-product.  Primary markets for biotechnology include:  1) Agriculture, where genetically modified seeds are now in wide use in many nations.  These seeds deliver plants that have…
Biotechnology, Pharmaceuticals & Genetics Industry Market Research

Engineering & Research Industry Market Research

In industrialized nations, R&D investment has risen from an average of about 1.5% of Gross Domestic Product (GDP) in 1980 to about 2.0% today (in terms of current US dollars).  Nothing could better illustrate the world’s vital need for continual massive investments in R&D than the Coronavirus pandemic that swept…
Engineering & Research Industry Market Research

Insurance, Risk Management & Reinsurance Market Research

Insurance and risk management make up an immense global industry.  According to a survey conducted by a leading global insurance firm, Swiss Re, worldwide insurance premiums totaled $7.3 trillion in 2022 (the latest data available).  In America alone, the insurance business employed about 2.94 million people as of July 2023…
Insurance, Risk Management & Reinsurance Market Research

Subscribe to Database:

All industries
Add To Cart

Multi-User Online, Enterprise-Wide (Library or Corporate)

Request a Quote and Free Trial

eBook or Book:

This industry onlyPublication date: Oct 2023
ISBN-13: 978-1-64788-506-9
ISBN-13: 978-1-64788-014-9
Custom Research Projects

What data challenge can we help you solve today?